BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22031092)

  • 1. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
    Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
    Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice.
    Themanns M; Mueller KM; Kessler SM; Golob-Schwarzl N; Mohr T; Kaltenecker D; Bourgeais J; Paier-Pourani J; Friedbichler K; Schneller D; Schlederer M; Zebedin-Brandl E; Terracciano LM; Han X; Kenner L; Wagner KU; Mikulits W; Kozlov AV; Heim MH; Gouilleux F; Haybaeck J; Moriggl R
    Sci Rep; 2016 Oct; 6():34719. PubMed ID: 27713471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
    Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
    Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
    Schneller D; Machat G; Sousek A; Proell V; van Zijl F; Zulehner G; Huber H; Mair M; Muellner MK; Nijman SM; Eferl R; Moriggl R; Mikulits W
    Hepatology; 2011 Jul; 54(1):164-72. PubMed ID: 21452288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
    Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
    J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration.
    Cui Y; Hosui A; Sun R; Shen K; Gavrilova O; Chen W; Cam MC; Gao B; Robinson GW; Hennighausen L
    Hepatology; 2007 Aug; 46(2):504-13. PubMed ID: 17640041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
    Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation.
    Miquet JG; González L; Matos MN; Hansen CE; Louis A; Bartke A; Turyn D; Sotelo AI
    J Endocrinol; 2008 Aug; 198(2):317-30. PubMed ID: 18480380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ames dwarf (Prop1(df)/Prop1(df)) mice display increased sensitivity of the major GH-signaling pathways in liver and skeletal muscle.
    Miquet JG; Muñoz MC; Giani JF; González L; Dominici FP; Bartke A; Turyn D; Sotelo AI
    Growth Horm IGF Res; 2010 Apr; 20(2):118-26. PubMed ID: 20022531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
    Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
    Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet.
    Baik M; Lee MS; Kang HJ; Park SJ; Piao MY; Nguyen TH; Hennighausen L
    Eur J Nutr; 2017 Mar; 56(2):569-579. PubMed ID: 26582580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone STAT5-mediated signaling and its modulation in mice liver during the growth period.
    Martinez CS; Piazza VG; Ratner LD; Matos MN; González L; Rulli SB; Miquet JG; Sotelo AI
    Growth Horm IGF Res; 2013; 23(1-2):19-28. PubMed ID: 23245546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance.
    Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D
    J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression.
    Kaltenecker D; Themanns M; Mueller KM; Spirk K; Suske T; Merkel O; Kenner L; Luís A; Kozlov A; Haybaeck J; Müller M; Han X; Moriggl R
    Cytokine; 2019 Dec; 124():154569. PubMed ID: 30389231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.
    Mueller KM; Themanns M; Friedbichler K; Kornfeld JW; Esterbauer H; Tuckermann JP; Moriggl R
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):1-11. PubMed ID: 22564914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5.
    Yu J; Zhao L; Wang A; Eleswarapu S; Ge X; Chen D; Jiang H
    Endocrinology; 2012 Feb; 153(2):750-8. PubMed ID: 22166977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.
    Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE
    Endocrinology; 2014 Jul; 155(7):2545-54. PubMed ID: 24708244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.